Remifentanil in Extracorporeal Shock Wave Lithotripsy
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the analgesic efficacy and side effects induced by
administration of two different infusion rates of remifentanil, 0,05 mcg/ Kg/ min versus
0,1mcg/ Kg/ min, in order to determine which one is the most appropriate analgesic treatment
to face extracorporeal shock wave lithotripsy.